Inorganic CsPbI2Br perovskite exhibits high thermal stability and superior optoelectronic properties and thus has been widely used in perovskite solar cells as a light absorber. Nevertheless, the unsatisfactory perovskite quality and severe charge recombination remarkably restrict the performance of the CsPbI2Br device. Herein, a strategy of controlling CsPbI2Br perovskite colloidal dispersion with 4-methoxybenzenethiol (MeOBT) is proposed for modulating the perovskite crystallization process and promoting CsPbI2Br perovskite quality. MeOBT is introduced into the CsPbI2Br precursor solution as a coordination additive. The strong interaction between MeOBT molecules and the haloplumbate framework triggers the disassembly of the precursor colloids in the precursor solution, reducing the perovskite nucleation sites and decreasing the perovskite growth rate. The slow perovskite nucleation and low crystal growth rate lead to formation of a large-grain and high-quality CsPbI2Br perovskite film. In addition, MeOBT molecules adsorb on the final perovskite film surface, protecting the perovskite film and passivating perovskite surface defect. With these benefits, the carbon-based CsPbI2Br perovskite solar cell that delivers a high power conversion efficiency of 14.08% and preserves ∼90% of the initial efficiency after 480 h storage in ambient conditions is fabricated.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: